|Date Closed:||May 02, 2018|
|Client Name:||Emerald Health Therapeutics|
On May 2, 2018 Emerald Health Therapeutics Inc. acquired all of the issued and outstanding securities of 8611165 Canada Inc. (doing business as Agro-Biotech), a private company which is a Québec based Licensed Producer under the Access to Cannabis for Medical Purposes Regulations (ACMPR) and an affiliated company for a purchase price of $90 million, payable half in cash and half in shares of Emerald.
Emerald Health Therapeutics is a British Columbia based Licensed Producer under the ACMPR and produces and sells dried cannabis and cannabis oil for medical purposes. The shares of Emerald are listed on the TSX Venture Exchange under the symbol “EMH”.
Agro-Biotech is a Licensed Producer under the ACMPR with a 75,000 square foot indoor cultivation facility in Saint-Eustache, Québec.
McCullough O’Connor Irwin LLP (now Bennett Jones LLP) were counsel to Emerald Health Therapeutics with a team consisting of James Beeby, Lisa Stewart, Lisa Andrews and Tajinder Rathor. BCF acted as Québec local counsel to Emerald Health Therapeutics with a team consisting of Gilles Seguin and Jean-François Noël. David Dubois, Avocats Inc. acted as counsel to Agro-Biotech with a team consisting of David Dubois and Stephanie Lemay.